»
Antikörper
»
anti-Myosin VIIA and Rab Interacting Protein (MYRIP) Antikörper
Myosin VIIA and Rab Interacting Protein (MYRIP) Antikörper
| Antigen |
|
| Synonyme |
SLAC2C, SLAC2-C, FLJ44025, MGC130034, MGC130035, DKFZp586F1018, Slac2c, Slac2-c, A230081N12Rik, MYRIP, LOC561671, LOC100156583 |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
|
| Produktnummer |
ABIN185041 |
| Menge |
100 ug |
| Preis |
286,00 € Zzgl. Versandkosten €40,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Weitere Bezeichnung
|
MYRIP / SLAC2C
|
|
Gen-ID
|
25924
|
|
Immunogen
|
C-KDLMEPALESAVMY
|
|
Format
|
Affinity-purified
|
|
Beschreibung
|
All names and symbols: MYRIP, SLAC2C, myosin VIIA and Rab interacting protein, MyRIP, SLAC2-C, exophilin, exophilin 8, DKFZp586F1018, rab effector MYRIP, Slp homologue lacking C2 domains, synaptotagmin-like protein homologue lacking C2 domains-c, FLJ44025, MGC130034, MGC130035. Official Symbol: MYRIP. RefSeq number(s): NP_056275.2
|
|
Spezifität
|
Human
|
|
Applikationshinweise
|
Peptide ELISA: antibody detection limit dilution 1:64,000. Western Blot: Approx 100kDa band observed in Human Duodenum lysates (calculated MW of 95.7kDa according to NP_056275.2). Recommended concentration: 0.1-0.3µg/ml.
|
|
Reinigung
|
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
|
|
Buffer
|
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
|
|
Lagerung
|
Aliquot and store at -20°C. Minimize freezing and thawing.
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
El-Amraoui, Schonn, Kuessel-Andermann et al.: "MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes." in: EMBO reports, Vol. 3, Issue 5, pp. 463-70, 2002 (PubMed).
|
Alternativen zu Antigen "Myosin VIIA and Rab Interacting Protein (MYRIP)", Typ "Antikörper" finden